EpiCrossBorder Symposium- International Helmholtz-Edinburgh Research School for Epigenetics

EpiCrossBorder Symposium- International Helmholtz-Edinburgh Research School for Epigenetics

EpiCrossBorders is an initiative between Helmholtz Munich and The University of Edinburgh to promote world-class collaborative research for PhD Students. This year the specific focus is on “Translating our Discoveries”. The programme includes a guest talk from Professor Neil Carragher (Institute for Genetics and Cancer) and Keynote by Allan Bradley. Allan was previously Director of the Sanger Institute and is a serial entrepreneur. His companies include Lexicon Pharmaceuticals, KyMab, and now T-Therapeutics.